Pressure BioSciences, Inc. announced that Mr. Conrad F. Mir has joined the company as its chief financial officer (CFO), effective immediately. Mr. Mir has over twenty years experience in investment banking, financial structuring, and corporate reengineering. He has served in various executive management roles and on the Board of Directors of several companies in the biotechnology industry.

Most recently, Mr. Mir was chairman and CEO of Genetic Immunity, Inc. (GI). Prior to GI, Mr. Mir served as executive director of Advaxis, Inc. During his tenure at GI and Advaxis, Mr. Mir was responsible for raising nearly $40 million in growth capital and broadening corporate reach to new investors and current shareholders.